Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for...
SEONGNAM South Korea Feb. 11 2019 PRNewswire Bridge Biotherapeutics Inc. a clinical stage biotech company headquartered in Seongnam South Korea announced that the company presented the preclinical and...
View ArticleLink between gut bacteria and mental health identified
Researchers from Belgiums KU Leuven have released what is said to be the first populationlevel study on the link between gut bacteria and mental health identifying specific gut bacteria linked to...
View ArticleZappRx and Teva Respiratory Collaborate to Speed Delivery of Specialty...
Partnership provides physicians using the ZappRx prescribing platform with a streamlined way to prescribe respiratory medication and provide access to associated programs ZappRx a healthcare...
View ArticleHuman medicines European public assessment report EPAR Entyvio vedolizumab...
Human medicines European public assessment report EPAR Entyvio vedolizumab Colitis UlcerativeCrohn Disease Date of authorisation 22052014 Revision 11 Status Authorised
View ArticleLandos Biopharma to begin dual phase 2 program in March possible IPO in 2020
Landos Biopharma Inc CEO Josep BassaganyaRiera sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.The Virginiabased clinicalstage biopharmaceutical company...
View ArticleMycenax Biotech Inc 4726 Pharmaceuticals Healthcare Deals and Alliances...
SummaryMycenax Biotech Inc Mycenax is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational...
View ArticleNash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease...
Nash Pharmaceuticals Inc. a wholly owned subsidiary of Breathtec Biomedical Inc.ÂCSEÂBTH CNSXÂBTH FRANKFURTÂBTI OTCQBÂBTHCFÂthe Company or Nash Pharma is pleased to announce that it has been accepted...
View ArticlePatients' own cells could be the key to treating Crohn's disease
NIHR Biomedical Research Centre at GuyÂs and St Thomas and KingÂs College London A new technique using patients' own modified cells to treat Crohn's disease has been proven to be effective in...
View ArticleTreg Cells Show Promise as Immunotherapy for Crohn's Disease
Crohn's disease CD symptoms may be reduced if an agonist of the retinoic acid receptor alpha RARA can be used to traffic Tregulatory Treg cells to inflamed intestinal tissues researchers suggest....
View ArticleAbundant T Cell Clones in Smokers Tied to Crohn's Recurrence
MedPage Today Smokers with T celldriven pathogenesis may benefit from targeted therapy
View ArticleNew technique using patients' own modified cells could help treat Crohn's...
A new technique using patients' own modified cells to treat Crohn's disease has been proven to be effective in experiments using human cells with a clinical trial of the treatment expected to start in...
View ArticleHuman medicines European public assessment report EPAR Hulio adalimumab...
Human medicines European public assessment report EPAR Hulio adalimumab Hidradenitis SuppurativaPsoriasisCrohn DiseaseUveitisArthritis RheumatoidColitis UlcerativeSpondylitis AnkylosingArthritis...
View ArticleLabCorp Strengthens Leadership Position in Precision Medicine with Expansion...
LabCorps DoseASSURE Portfolio Provides Most Expansive Biologics TDM Menu Combined with Expert Guidance LabCorp NYSE LH a leading global life sciences company that is deeply integrated in guiding...
View ArticleMedical News Today Treating constipation in Crohn's disease
Crohn's disease typically causes frequent diarrhea but some people also have constipation. Constipation can result from medications or strictures and treatment options include dietary and lifestyle...
View ArticleMetabolite produced by gut microbiota from pomegranates reduces inflammatory...
It is known that inflammatory bowel diseases IBD consisting of Crohns and ulcerative colitis are caused by dysregulation of the immune system leading to intestinal inflammation and microbial changes....
View ArticleKoutif Therapeutics Announces FDA Acceptance of IND Application for Novel New...
Koutif Therapeutics today announced that its investigational new drug IND application for KT1002 has been cleared by the US Food and Drug Administration to begin a Phase 1 clinical trial for the...
View ArticleLandos Biopharma Announces Publication Supporting Novel Dual Mechanism of...
Landos Biopharma Inc. a clinicalstage biopharmaceutical company focused on the discovery and development of firstinclass oral therapeutics for patients with autoimmune diseases announced the...
View ArticleGene Missense Variant Associated with Crohn's Disease
Genemicrobiome interactions are important in etiology and pathogenesis of inflammatory bowel disease a chronic inflammatory disorder of the gastrointestinal tract...
View ArticleCrohn&39;s disease treatment could lie in patients&39; own cells
UK researchers have developed a technique that uses Crohns disease patients own modified cells to treat the condition with a clinical trial expected to start in the next six months. Their work has been...
View Article